In Hodgkin's disease there is an early and consistent depression of delayed (cell-mediated) hypersensitivity (1) (2) (3) . The mechanism of this immunological defect is unknown, and its elucidation may throw light on the process of cellular hypersensitivity and on the pathogenesis of Hodgkin's disease. Recently, Gray and Russell (4) have described a lymphocyte transfer technique for screening donor/recipient compatibility in human homotransplantation in which purified lymphocytes are transferred from the proposed recipient into the skin of a panel of proposed donors. The test is closely modeled after a similar technique employed by Brent and Medawar (5, 6) in guinea pigs. In essence it is assumed that the reaction of the transferred recipient lymphocytes against the proposed donor skin (a graft-versus-host phenomenon) is based on histocompatibility differences and that the intensity of this reaction predicts the severity of the ensuing host attack on the grafted organ. In the guinea pig this conclusion appears justified, but at this time critical evaluation of the human lymphocyte transfer reaction is incomplete.
Recognizing the shortcomings imposed by limited knowledge about the normal lymphocyte transfer reaction in man, we still felt that the Hodgkin's patient offered a unique situation for study of the phenomenon. This paper represents the conclusions drawn from 85 transfers of Hodgkin's and normal peripheral lymphocytes to Hodgkin's and non-Hodgkin's individuals. Although many of the questions raised by the present work remain unanswered, it has given additional insight into the mechanism of the human lympho-* Submitted for publication July 22, 1964; accepted December 3, 1964. This investigation was supported by grant CA-07179 of the National Cancer Institute, U. S. Public Health Service. This is publication no. 1188 of the Cancer Commission of Harvard University.
cyte transfer reaction and has suggested a lymphocyte defect in Hodgkin's disease.
Methods
Selection of patients. Hodgkin's disease patients selected as either donors or recipients, with one exception, were the same patients employed in an earlier study (7) where anergy had been established by failure to develop (8, 9 ) that such cancer patients are not anergic inasmuch as they respond to a battery of delayed allergens (diptheria toxoid, streptokinase-streptodornase, mumps skin test antigen, Trichophyton gypseum, Candida albicans, and tuberculin PPD) in the same way as a control population. In the present work only three of the non-Hodgkin's recipients (VS, EA, and MT) were studied in this way, but all reacted strongly to one or more of these allergens. Preparation of lymphocytes. Only minor modifications have been made in the technique of Gray and Russell (4) for the preparation of human lymphocytes. The initial volume of blood to be defibrinated was increased to 50 ml, but the defibrinated blood was diluted as these authors suggest in the ratio of 1 ml of 3.5% polyvinylpyrrolidone (PVP, mol wt 25,000) to 2.5 ml blood. The diluted blood was allowed to settle for 90 minutes at room temperature. The buffy coat obtained from this sedimentation was centrifuged (1,500 rpm for 5 minutes), resuspended, and recentrifuged (800 rpm for 5 minutes) without modification (4).
When employing blood from Hodgkin's patients, separation of lymphocytes and granulocytes on the final centrifugation is variable, and considerable judgment is re-555 quired in selecting the appropriate part of the supernatant for the lymphocyte preparations. With some Hodgkin's samples lymphocyte preparations of excellent purity were obtained from this supernatant, whereas with others essentially all the lymphocytes were present in the upper part of the centrifuged layer and had to be recovered to obtain an adequate yield. At best, Hodgkin's disease blood with high and variable sedimentation rates, high polymorphonuclear and platelet counts, and low lymphocyte counts (10) is a poor source for lymphocyte preparations of high purity.
Reading of tests. In Tables I to V the induration in millimeters of the averaged longitudinal and transverse diameters of the skin reactions is entered, and erythema without induration or exceeding induration is entered as a number within parentheses. Where unspecified by (Tables II and III) and six non-Hodgkin's in-dividuals (Table IV) are presented in detail in Tables I to IV and summarized in Table V. Although Table V presents an over-all summary of the work, it is only by examination of Tables II to IV that differences in reactivity between Hodgkin's and normal lymphocytes in the same recipient can be appreciated. Tables II and III and summarized  in Table V Hodgkin's lymphocytes is illustrated in Figure  1 , a photograph of the 7-day reaction in Hodgkin's recipient 8 of (Table IV, recipients 2, 3 , 5, and 6). Repeat transfers involving a second donor and the same recipient were done only a few times, but in these few there was no clear evidence that the first reaction had influenced the second. Discussion
Although the transfer of lymphocytes from one individual to another is operationally simple, on a theoretical level it represents a most complex phenomenon. Immunological reactivity in two directions is possible, either from grafted lymphocytes against host or from host against graft. Both of these reactions could be expected to be modified or determined by the respective histocompatibility antigens of host and graft, and in both, reactivity residing in donor and host lymphoid cells at the time of transfer and that developing after the delay required for sensitization in immunological systems must be considered.
Finally, the strong possibility exists that at least part of the skin reaction seen after lymphocyte transfer is not immunological in nature.
Before proceeding with the major argument, a second point should be considered: the immunological status of the non-Hodgkin's recipient. The normal immunological status of the metastatic cancer patient in good general condition is assumed only on the basis of the reactivity to a battery of skin allergens which, in patients of this type, parallels that of a normal population. In point of fact only three of our five non-Hodgkin's recipients were evaluated in this way, a defect of the present experiments.
With this in mind it is significant that a difference in reactivity between lymphocytes of the anergic Hodgkin's patient and the normal could be observed. This difference was not clearly seen at 48 hours, but was quite evident at 7 and 11 to 14 days, when the reaction of the Hodgkin's lymphocyte was observed to fade out and the normal lymphocyte reaction persisted. The difference between the Hodgkin's and normal lymphocyte was more conclusive in the Hodgkin's than in the non-Hodgkin's recipient. This is probably related to the longer and more complete evolution of the reaction of transferred normal cells in the anergic Hodgkin's recipient; this permits a longer period after subsidence of the initial reaction of the Hodgkin's cells when the persisting reaction of the normal cells can be observed. If we posit an important role of lymphoid blood cells in the mediation of delayed hypersensitivity [for which there is considerable evidence (12) (13) (14) (15) ], the lymphocyte defect manifest in the abnormal transfer reaction of Hodgkin's cells presumably contributes to the depression of delayed hypersensitivity seen in active Hodgkin's disease. The depression of circulating lymphocytes reported in Hodgkin's disease (10) may also contribute to the anergy, but does not influence the transfer reaction, since equal numbers of normal and Hodgkin's cells have been employed in the present experiments. [A preliminary report on lymphocyte transfer reactions in uremic subjects suggests a defect in uremic lymphocytes (16) ].
A second abnormality emerges when the Hodgkin's patient is compared with the non-Hodgkin's as recipient rather than as lymphocyte donor. A group of Hodgkin's patients, three of the four with far advanced disease, displayed depressed 48-hour reactions to both normal and Hodgkin's lymphocytes. Finally, the reaction of the normal lymphocyte in the Hodgkin's individual was protracted beyond that of normal cells in normal or non-Hodgkin's recipients. This last is reasonably explained by the delayed rejection of the transferred normal lymphocyte in the anergic Hodgkin's recipient, an explanation consistent with the delayed rejection of skin homografts observed in Hodgkin's disease (17) (18) (19) , and is closely parallel to the enhanced lymphocyte transfer reaction seen in irradiated guinea pig recipients (20) . Our observations on the transfer reactions of normal cells in non-Hodgkin's recipients support the idea that sensitization of the host contributes to the termination of the transfer reaction and the corollary that the delay in homograft rejection seen in the Hodgkin's patient results in a protracted reaction of normal transferred lymphocytes, i.e., second transfers of the same donor lymphocytes to the same recipient result in an abbreviated reaction.
The abnormality that the Hodgkin's patient displays as recipient, discussed in the preceding paragraph, is less regular than the defect of the transferred Hodgkin's lymphocyte. This suggests that the two phenomena reflect separate immunological deficiencies or that the first-mentioned is a manifestation of a more advanced anergic state than the latter. It must be conceded that Hodgkin's disease is not an immunological entity, but a clinical condition with varying involvement of the reticuloendothelial system. Although a depression of delayed hypersensitivity is detectable early in the course of the illness before the disease is generalized, there is every reason to believe that the anergy is not complete at the outset and progresses with advancing disease. For this reason the four patients with far advanced Hodgkin's disease were separated from the remainder of the Hodgkin's patients for consideration in the tables. It is possible that the additional defect in the transfer reaction of these far advanced Hodgkin's recipients (depressed 48-hour reaction) reflects the les specific type of anergy seen in the debilitated cancer patient (9) .
The present studies raise certain questions about the nature of the normal human lymphocyte transfer reaction. Brent and Medawar (6) consider the early reaction (24 to 48 hours) in the guinea pig to be graft-versus-host, whereas the later reaction (4 days) is assumed to be hostversus-graft. Recently, these workers (20) demonstrated that F1 hybrid lymphocytes fail to give the early transfer reactions in inbred parentalstrain recipients, whereas reactions were obtained with parental lymphocytes transferred to the F1 hybrid, compelling evidence that in the guinea pig the early reaction is largely graft-versus-host in character (4) .
On the basis of the similar behavior of different lymphocyte preparations (from both Hodgkin's and normal donors) in the same recipient (either Hodgkin's or non-Hodgkin's), the present experiments suggest that host rather than donor factors are important in the early lymphocyte transfer reaction. Clearly, we cannot exclude granulocyte contamination or residual immunological reactivity of the Hodgkin's patient from contributing to the early (48-hour) reactions of Hodgkin's lymphocytes. However, immunological reactivity as measured by the ability of the lymphocyte donor to develop sensitization with dinitrochlorobenzene certainly correlates much better with the late (7-and 11-to 14-day) reactions than with the early one. On the basis of the present work it would seem more likely that the early reaction reflects a more primitive type of immunological reactivity or perhaps is not even strictly immunological in nature. Nevertheless, since the early reaction is not seen in autologous transfers, it clearly does have something to do with individuality and by suitable control of host reactivity may still serve as an assay of graft-host histocompatibility (4) . If the lymphocyte transfer reaction could be assumed to evolve much more slowly in man than in the guinea pig, much of the conflict of interpretation between the present work and that of Brent and Medawar (6) could be resolved.
In a number of transfer reactions, among both normal and Hodgkin's recipients, a substantially greater reaction was found at 7 days and later than at 48 hours. This finding is consistent with the development of sensitization against the host within the grafted lymphocytes, although it is certainly open to other explanations.
Thus, in addition to suggesting a qualitative difference in the lymphocytes of patients with Hodgkin's disease, the present investigations are compatible with certain interpretations of the normal lymphocyte transfer reaction. The initial reaction at 48 hours appears to be largely host determined, whether on an immunological or nonimmunological basis is not clear. At later time periods this host component subsides, and the 7-day and later reactions appear to be primarily graft-versus-host in nature (arguing from the failure of Hodgkin's disease lymphocytes to react at this time). Finally, sensitization of the host seems to terminate the reaction without any new visible event. It must be recognized that with the theoretical complexities of the lymphocyte transfer reaction, this formulation must remain tentative. Summary Eighty-five lymphocyte transfer reactions employing six non-Hodgkin's and 12 Hodgkin's recipients have been studied. The skin reaction of transferred Hodgkin's lymphocytes is only slightly impaired at 48 hours, but is markedly depressed at 7 days and at 11 to 14 days compared with normal lymphocytes transferred to the same recipient. The difference between Hodgkin's and normal lymphocytes is best observed in the Hodgkin's recipient, where the duration of the transfer reaction of normal lymphocytes is abnormally protracted. The defect of the Hodgkin's lymphocyte is presumed to contribute to the cutaneous anergy seen in Hodgkin's disease.
On the basis of the present studies, it is felt most likely that host factors are important in the 48-hour lymphocyte transfer reaction, whereas the 7-day reaction is a graft-versus-host phenomenon.
The 48-hour reaction appears to reflect a different (more primitive) type of immunological response than the later reactions; only the later reactions correlate well with the anergy of the lymphocyte donor. Termination of the transfer reaction is believed to be caused by sensitization of the host with rejection of the transferred lymphocytes.
